| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/09/2009 | CN101525626A Expression vector containing IER5 gene, monoclonal cell line and application thereof |
| 09/09/2009 | CN101525616A Preparation and application of sperm binding protein HEL-127 specifically expressed in human epididymis |
| 09/09/2009 | CN101525615A Defensins gene expressed in human epididymis, and cloning, expression and application of same |
| 09/09/2009 | CN101525610A Application of earthworm fibronectin enzyme in treating hepatitis B |
| 09/09/2009 | CN101525598A Method for purifying human urinary trypsin inhibitor |
| 09/09/2009 | CN101525390A Kappa-carrageenin oligose selenizing derivate, preparation method thereof and application for being used as medicine |
| 09/09/2009 | CN101525385A Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases |
| 09/09/2009 | CN101525374A Pentapeptide derivative, preparation method and applications thereof |
| 09/09/2009 | CN101525365A Strong water-soluble derivative of cholestane-3 beta, 5 alpha, 6 beta-triol |
| 09/09/2009 | CN101525364A Crystal form of fulvestrant and preparation method thereof |
| 09/09/2009 | CN101525324A Method for separating genistein monomer from daidzein monomer |
| 09/09/2009 | CN101525323A Novel styryl chromone type compound and preparation method and use thereof |
| 09/09/2009 | CN101525289A Method for separating purified ginkgoic acid with anion exchanger |
| 09/09/2009 | CN101524548A Nanometer carrier combination and application thereof to preparation of anti-tumor drug |
| 09/09/2009 | CN101524546A Conjugate conjugated from polyethylene glycol and curcumin derivative |
| 09/09/2009 | CN101524529A Treatment on human malignant solid tumor by HNF4 alpha inducement and differentiation |
| 09/09/2009 | CN101524528A Recombination NuBCP-9 and Tumstatin(74-98) antitumor fusion polypetide |
| 09/09/2009 | CN101524527A TAT-HOXB4H fusion protein used as hematopoiesis irritant and the pharmaceutical composition thereof |
| 09/09/2009 | CN101524520A Chinese medicinal composition for resisting chronic gastritis and preparation method thereof |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524485A Application of sorghum in preparing anticancer medicaments |
| 09/09/2009 | CN101524473A Worm grass anticancer longevity pellet and preparation method thereof |
| 09/09/2009 | CN101524465A External dipping medicine for remedying cancer |
| 09/09/2009 | CN101524452A Chinese medicinal composition for treating hyperplasia of mammary glands and preparation method thereof |
| 09/09/2009 | CN101524442A Medicine for treating cancer and preparation method thereof |
| 09/09/2009 | CN101524436A Chinese medicinal composition for treating lung cancer |
| 09/09/2009 | CN101524423A Sour traditional Chinese medical pill for treating cancerous pain |
| 09/09/2009 | CN101524405A Traditional Chinese medicine composition for treating tumour |
| 09/09/2009 | CN101524393A Preparation method of gypenoside |
| 09/09/2009 | CN101524391A Quality control method for Xihuang pills |
| 09/09/2009 | CN101524382A Method for preparing general flavone in fourcorneous water caltrop |
| 09/09/2009 | CN101524378A Anti-ageing traditional Chinese medicine preparation |
| 09/09/2009 | CN101524377A Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
| 09/09/2009 | CN101524376A Extrusion wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524375A Wet-process wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524348A Application of tea polyphenol in preparing medicament for treating tumor |
| 09/09/2009 | CN101524343A Application of valproate and salt-induced redifferentiation combined with <131> iodine thereof in treating poor differentiation/dedifferentiation thyroid cancer |
| 09/09/2009 | CN101524341A Use of isoliquiritigenin in preparation of auxiliary therapeutic medicine for tumor radiation therapy |
| 09/09/2009 | CN101524337A Prolonged release mucosal bioadhesive system |
| 09/09/2009 | CN101524331A Polysaccharide-liposome and preparation method and purpose thereof |
| 09/09/2009 | CN101524326A Chlorin e6 chitosan-stearic acid graft micelle |
| 09/09/2009 | CN100537761C Trans-oligonucleotide, medicinal composition containing it and use thereof |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537568C 6-substituted pyridoindolone derivatives, production method and therapeutic use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100537542C Farnesyl protein transferase inhibitors as antitumor agents |
| 09/09/2009 | CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536922C Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/09/2009 | CN100536857C Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug |
| 09/09/2009 | CN100536850C Combinations comprising staurosporines |
| 09/09/2009 | CN100536841C Cyclopropyl and cyclobutyl epothilone analogs |
| 09/09/2009 | CN100536840C Combinations of anti-cancer agents |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/09/2009 | CN100536691C Compositions containing coenzyme Q10 |
| 09/08/2009 | US7585985 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 09/08/2009 | US7585973 chemical synthesis for forming a conjugate of anticancer drug with folic acid; chemotherapy drug |
| 09/08/2009 | US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 09/08/2009 | US7585966 Directed against accessible regions in the telomerase ribonucleoprotein; cancer |
| 09/08/2009 | US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 09/08/2009 | US7585952 Fully human miniantibody (scFv) called Erbicin, specific for the receptor ErbB2; antitumor; transmembrane tyrosine kinase receptor |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585893 Anti-cancer composition comprising DMXAA or related compound |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585869 novel bicyclic derivatives that are useful in the treatment of abnormal cell growth, such as cancer; tyrosine kinase inhibitors |
| 09/08/2009 | US7585868 Antagonists of a lipid kinase such as a PI3 kinase, protein tyrosine kinase, and/or protein serine-threonine kinases such as mTOR; 1-isopropyl-3-(3-methoxy-4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
| 09/08/2009 | US7585866 Protein tyrosine kinase inhibitors |
| 09/08/2009 | US7585863 Antitumor agents; such as (2-(4-(7-Chloro-2-quinoxalinyl)oxy)propionylamino ethansulfonic acid; {2-{4-(7-Chloro-quinoxalin-2-yloxy)-phenoxy}propionyl amino}acetic acid |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585857 Cytotoxic agents comprising taxanes and their therapeutic use |
| 09/08/2009 | US7585855 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 09/08/2009 | US7585834 Transport moiety comprises a structure; (ZYZ)nZ, (ZY)nZ, (ZYY)nZ or (ZYYY)nZ, wherein each Z is L-arginine or D-arginine, and each Y is independently an amino acid that does not comprise an amidino or guanidino moiety; n=2-10 |
| 09/08/2009 | US7585666 genetically engineered chimeras comprising ligand binding domain fused to an effector domain of an apoptosis signaling molecule and second encoding a cis acting regulatory element; for use in/ex vivo |
| 09/08/2009 | US7585642 Methods for evaluating the quality of a heparin sample |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585519 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585497 Comprises nucleotide sequences coding insulin-like growth factor binding protein-3 and receptors for diagnosis, prevention and treatment of cancer; antitumor/anticarcinogenic agents |
| 09/08/2009 | US7585491 Immunoconjugates with an intracellularly-cleavable linkage |
| 09/08/2009 | CA2520901C Pyrene-linked pyrrolo (2,1-c) (1,4) benzodiazepine derivatives useful as anticancer agents |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2009 | CA2455425C Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
| 09/08/2009 | CA2442270C Inhibitors of akt activity |
| 09/08/2009 | CA2409546C Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/08/2009 | CA2401160C Biologically active analogs of discodermolide |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 09/08/2009 | CA2319032C New cytotoxic tris(oxazole)-containing macrolides |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/08/2009 | CA2293714C Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2286560C Vinca alkaloid antimitotic halogenated derivatives |
| 09/08/2009 | CA2284750C Steroid sulfamates, method for the production and use thereof |
| 09/08/2009 | CA2249439C Combination of a somatostatin analogue and a rapamycin |
| 09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 09/07/2009 | CA2657526A1 Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
| 09/07/2009 | CA2624883A1 Directed therapy |